NO305796B1 - Pyrrolidenmetylderivater, farmas°ytiske preparater inneholdende slike, deres anvendelse til fremstilling av terapeutika samt mellomprodukt - Google Patents

Pyrrolidenmetylderivater, farmas°ytiske preparater inneholdende slike, deres anvendelse til fremstilling av terapeutika samt mellomprodukt

Info

Publication number
NO305796B1
NO305796B1 NO953280A NO953280A NO305796B1 NO 305796 B1 NO305796 B1 NO 305796B1 NO 953280 A NO953280 A NO 953280A NO 953280 A NO953280 A NO 953280A NO 305796 B1 NO305796 B1 NO 305796B1
Authority
NO
Norway
Prior art keywords
alkyl
alkoxy
alkenyl
substituted
unsubstituted
Prior art date
Application number
NO953280A
Other languages
English (en)
Norwegian (no)
Other versions
NO953280D0 (no
NO953280L (no
Inventor
Gianfederico Doria
Anna Maria Isetta
Marcellino Tibolla
Maria Chiara Fornasiero
Mario Ferrari
Domenico Trizio
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO953280D0 publication Critical patent/NO953280D0/no
Publication of NO953280L publication Critical patent/NO953280L/no
Publication of NO305796B1 publication Critical patent/NO305796B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
NO953280A 1993-12-23 1995-08-21 Pyrrolidenmetylderivater, farmas°ytiske preparater inneholdende slike, deres anvendelse til fremstilling av terapeutika samt mellomprodukt NO305796B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939326284A GB9326284D0 (en) 1993-12-23 1993-12-23 Pyrrolydenemethyl-derivatives and process for their preparation
PCT/EP1994/004006 WO1995017381A1 (en) 1993-12-23 1994-12-02 Novel 2,2'-bi-1h-pyrrole derivatives with immunosuppressant activity

Publications (3)

Publication Number Publication Date
NO953280D0 NO953280D0 (no) 1995-08-21
NO953280L NO953280L (no) 1995-08-21
NO305796B1 true NO305796B1 (no) 1999-07-26

Family

ID=10747089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953280A NO305796B1 (no) 1993-12-23 1995-08-21 Pyrrolidenmetylderivater, farmas°ytiske preparater inneholdende slike, deres anvendelse til fremstilling av terapeutika samt mellomprodukt

Country Status (25)

Country Link
US (1) US5691334A (hu)
EP (2) EP1241162A1 (hu)
JP (1) JP3594311B2 (hu)
KR (1) KR100365057B1 (hu)
CN (1) CN1120153C (hu)
AT (1) ATE224874T1 (hu)
AU (1) AU689169B2 (hu)
CA (1) CA2155096A1 (hu)
DE (1) DE69431429T2 (hu)
DK (1) DK0686147T3 (hu)
ES (1) ES2184786T3 (hu)
FI (1) FI109688B (hu)
GB (1) GB9326284D0 (hu)
HU (1) HUT73663A (hu)
IL (1) IL112022A (hu)
MY (1) MY113304A (hu)
NO (1) NO305796B1 (hu)
NZ (1) NZ276716A (hu)
PL (1) PL183112B1 (hu)
PT (1) PT686147E (hu)
RU (1) RU2145957C1 (hu)
TW (1) TW285670B (hu)
UA (1) UA57697C2 (hu)
WO (1) WO1995017381A1 (hu)
ZA (1) ZA9410203B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1009856A5 (fr) * 1995-07-14 1997-10-07 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
GB9603212D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Process for the preparation of 2,2'-bipyrrolyl-pyrromethane derivatives
GB9619706D0 (en) * 1996-09-20 1996-11-06 Pharmacia Spa Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole comp und
GB9705035D0 (en) * 1997-03-11 1997-04-30 Pharmacia & Upjohn Spa Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
US5989591A (en) * 1997-03-14 1999-11-23 American Home Products Corporation Rapamycin formulations for oral administration
KR100252197B1 (ko) * 1997-09-20 2000-04-15 박호군 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신
GB9802745D0 (en) 1998-02-09 1998-04-08 Pharmacia & Upjohn Spa Benzyloxy prodigiosine compounds
US6407244B1 (en) 2000-01-26 2002-06-18 Gemin X Biotechnologies Inc. Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases
US20040014987A1 (en) * 2000-01-26 2004-01-22 Gemin X Biotechnologies Inc. Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases
KR20010081515A (ko) * 2000-02-15 2001-08-29 복성해 프로디지오신의 당뇨병 예방 및 치료용 조성물
KR100392225B1 (ko) * 2001-04-19 2003-07-22 한국생명공학연구원 류머티스 관절염 치료용 프로디지오신 조성물
MXPA04000402A (es) * 2001-07-18 2004-03-18 Gemin X Biotechnologies Inc Compuestos de tipo pirrol, composiciones que los contienen, y metodos que los emplean para el tratamiento de cancer y enfermedades virales y para causar inmunosupresion.
KR101168441B1 (ko) 2003-05-30 2012-07-25 게민 엑스 파마슈티컬스 캐나다 인코포레이티드 암 또는 바이러스 질환의 치료를 위한 삼복소환 화합물,조성물 및 방법
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
WO2006089397A1 (en) * 2005-02-22 2006-08-31 Gemin X Biotechnologies Inc. Methods for treating arthritis using triheterocyclic compounds
KR100674222B1 (ko) * 2005-07-11 2007-01-24 한국생명공학연구원 세라시아 마르세센스 b-1231 kctc 0386bp로부터분리한 프로디지오신을 유효성분으로 포함한 급성이식편대숙주병의 예방 및 치료용 조성물
JP5438975B2 (ja) 2006-01-06 2014-03-12 サノビオン ファーマシューティカルズ インク テトラロン系モノアミン再取り込み阻害剤
RU2430913C2 (ru) 2006-01-06 2011-10-10 Сепракор Инк. Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
DK2013835T3 (en) 2006-03-31 2015-12-14 Sunovion Pharmaceuticals Inc Preparation of chiral amides and AMINES
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US20080051400A1 (en) * 2006-07-06 2008-02-28 Gemin X Biotechnologies Inc. Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
CN103387529B (zh) * 2013-07-30 2016-03-30 中国农业科学院烟草研究所 抗tmv的三吡咯环类化合物及其制备方法和用途
ES2615077B1 (es) * 2015-12-02 2018-03-14 Universidad De Burgos Una nueva familia de compuestos, procedimiento de obtención de los mismos y sus usos en el tratamiento y/o profilaxis de enfermedades

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280429A (ja) * 1985-06-06 1986-12-11 Chugai Pharmaceut Co Ltd 免疫抑制剤
SU1409276A1 (ru) * 1985-11-10 1988-07-15 Донецкий медицинский институт им.М.Горького Способ лечени острых кишечных инфекций
JPH02250828A (ja) * 1989-03-23 1990-10-08 Nippon Kayaku Co Ltd 新規免疫抑制剤

Also Published As

Publication number Publication date
JPH08507090A (ja) 1996-07-30
IL112022A (en) 1998-12-27
AU689169B2 (en) 1998-03-26
DE69431429D1 (de) 2002-10-31
CN1120153C (zh) 2003-09-03
RU2145957C1 (ru) 2000-02-27
DK0686147T3 (da) 2003-02-03
US5691334A (en) 1997-11-25
FI953919A0 (fi) 1995-08-21
EP0686147A1 (en) 1995-12-13
CA2155096A1 (en) 1995-06-29
HUT73663A (en) 1996-09-30
PT686147E (pt) 2003-02-28
UA57697C2 (uk) 2003-07-15
EP0686147B1 (en) 2002-09-25
EP1241162A1 (en) 2002-09-18
DE69431429T2 (de) 2003-05-15
NO953280D0 (no) 1995-08-21
CN1118164A (zh) 1996-03-06
AU1109095A (en) 1995-07-10
KR100365057B1 (ko) 2003-06-09
TW285670B (hu) 1996-09-11
NO953280L (no) 1995-08-21
PL310387A1 (en) 1995-12-11
JP3594311B2 (ja) 2004-11-24
KR960701009A (ko) 1996-02-24
ZA9410203B (en) 1995-10-20
PL183112B1 (pl) 2002-05-31
IL112022A0 (en) 1995-03-15
NZ276716A (en) 1996-12-20
ATE224874T1 (de) 2002-10-15
MY113304A (en) 2002-01-31
FI953919A (fi) 1995-08-21
GB9326284D0 (en) 1994-02-23
ES2184786T3 (es) 2003-04-16
FI109688B (fi) 2002-09-30
HU9502782D0 (en) 1995-11-28
WO1995017381A1 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
NO305796B1 (no) Pyrrolidenmetylderivater, farmas°ytiske preparater inneholdende slike, deres anvendelse til fremstilling av terapeutika samt mellomprodukt
HK1026700A1 (en) 1,4-Substituted cyclic amine derivatives or dihydroindole derivatives and medicament thereof.
AU1163492A (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analog
HUP0001154A2 (hu) 3-Piperidil-4-oxo-kinazolin-származékok és a vegyületeket tartalmazó gyógyászati készítmények
FI931763A (fi) 4,1-bensoxazepinderivat och deras anvaendning
DK0565377T3 (da) Terapeutiske midler til behandling af Parkinsons sygdom
IL113778A (en) Condensed-indan derivatives pharmaceutical compositions containing the same and methods for the preparation thereof
US5021413B1 (en) Analgesic thiomorpholins, their preparation, and pharmaceutical compositions containing them
MX9707768A (es) Proceso para preparacion de derivados de 2,2'-bipirrolil- pirrometeno (prodigiosinas).
AU6158486A (en) Dihydro pyridine derivatives
FR2702477B1 (fr) Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.
MY131762A (en) Pharmaceutical compounds
ATE102199T1 (de) 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen.
DK1155012T3 (da) Dihydroquinazolinderivater med anti-cancer-aktivitet
WO1999029309A3 (en) 2,2'-bi-1h-pyrrole derivatives useful in the treatment of leukemia brought on by htlv-i
MX9803920A (es) Composicion sinergica inmunosupresora que contiene un compuesto de 2,2'-bi-1h-pirrol.
TW360642B (en) 1,4-Benzoxazine derivatives
DE68912055D1 (de) Aryloxy-, Arylthio-, Heteroaryloxy-, Heteroarylthio-Alkenylen-Derivate von Aminen.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.